Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Inmaculada Bellido-Estevez is active.

Publication


Featured researches published by Inmaculada Bellido-Estevez.


PLOS ONE | 2016

Assessing Potentially Inappropriate Prescribing in Community-Dwelling Older Patients Using the Updated Version of STOPP-START Criteria: A Comparison of Profiles and Prevalences with Respect to the Original Version

Encarnación Blanco-Reina; Maria Rosa García-Merino; Ricardo Ocaña-Riola; Lorena Aguilar-Cano; Jennifer Valdellós; Inmaculada Bellido-Estevez; Gabriel Ariza-Zafra

Emerging and changing evidence made it necessary to update STOPP-START criteria, and version 2 was published recently. In this study the objectives were to determine the prevalence of potentially inappropriate medication prescribing (PIM) in primary care using STOPP versions 1 (v1) and 2 (v2), as well as 2012 AGS Beers criteria, and analyze the factors associated with inappropriate prescribing according to STOPP/START v2. A cross-sectional study was carried out including community-dwelling older adults over the age of 65. Sociodemographic, clinical, functional and comprehensive drug therapy data were collected. The primary endpoint was the percentage of patients receiving at least one PIM. This variable was measured using three tools: STOPP v1, 2012 AGS Beers criteria and STOPP v2. Similarly, the percentage of patients receiving at least one potential prescribing omission (PPO) was calculated using START versions 1 and 2. A total of 1,615 prescriptions were reviewed. The median number of medications per patient was 7.1 drugs (±3.8). The prevalence of elderly people exposed to polypharmacy (≥5 medications) was 72.9%, whereas 28.4% of the participants took ≥10 drugs regularly. PIM were present in 18.7%, 37.3% and 40.4% of participants, according to the STOPP v1, 2012 Beers criteria and STOPP v2, respectively. According to STOPP v2, the number of medications taken (OR: 1.14, 1.06–1.25), the presence of a psychological disorder (OR: 2.22, 1.13–4.37) and insomnia (OR: 3.35, 1.80–6.32) were risk factors for taking a PIM. The prevalence of PPOs was 34.7% and 21.8% according to version 1 and 2, respectively. In conclusion, STOPP-START criteria have been remarkably modified, which is evidenced by the different prevalence rates detected using version 2, as compared to version 1. In fact, the level of agreement between version 1 and the updated version is only moderate. Special attention should be paid on benzodiazepines, which keep being the most frequent PIM.


Atencion Primaria | 2015

Estudio de las prescripciones farmacológicas en niños a nivel de atención primaria: evaluación de los usos off-label o fuera de ficha técnica

Encarnación Blanco-Reina; M. Auxiliadora Vega-Jiménez; Ricardo Ocaña-Riola; Elisa Isabel Márquez-Romero; Inmaculada Bellido-Estevez

Resumen Objetivo Evaluar el perfil de prescripción y los usos off-label (fuera de ficha técnica [FT]) y unlicensed (medicamentos no autorizados específicamente para niños) de medicamentos a nivel ambulatorio. Diseño Estudio transversal. Emplazamiento Consultas de pediatría de 2 centros de salud urbanos y sala de urgencia general del Hospital Materno-Infantil de Málaga. Participantes Niños de 0-14 años que acudiesen a consulta y se les prescribiese al menos un medicamento. Mediciones principales Variables sociodemográficas, motivo de consulta y medicación. Clasificación de las prescripciones según información contenida en FT. Resultados Se incluyeron un total de 388 niños, una submuestra de 105 (27%) atendidos en urgencias, y se valoraron 462 prescripciones, que involucraron 74 principios activos diferentes. Cada niño recibió un promedio de 1,7 fármacos (IC 95%: 1,6-1,9), siendo los más prescritos ibuprofeno, paracetamol, amoxicilina-clavulánico y budesonida. El grupo terapéutico más empleado y con mayor variedad de fármacos fue el respiratorio. El 27,4% de las prescripciones (IC 95%: 23,5-31) fueron off-label, constituyéndose como causa más frecuente el uso del fármaco para una edad distinta de la autorizada (60%; IC 95%: 54,1-63), seguida de distinta dosis (21,5%; IC 95%: 18-25), diferente indicación (12%; IC 95%: 9,2-15) y el 7% por distinta vía de administración (IC 95%: 5,4-10). Conclusiones La tasa de usos off-label presenta cifras intermedias, pudiendo recibir este tipo de prescripciones una tercera parte de los niños. Esto no significa que sean prescripciones incorrectas, pero es recomendable respaldarlas con la mejor evidencia, así como seguir las directrices de la normativa sobre medicamentos en situaciones especiales.


European Journal of Clinical Pharmacology | 2015

Optimizing elderly pharmacotherapy: polypharmacy vs. undertreatment. Are these two concepts related?

Encarnación Blanco-Reina; Gabriel Ariza-Zafra; Ricardo Ocaña-Riola; Matilde León-Ortíz; Inmaculada Bellido-Estevez


Archive | 2016

Objective Structured Clinical Examinations (OSCE) improved communication skills of student of Pharmacology in Medicine and Podiatry degree.

Inmaculada Bellido-Estevez; Encarnación Blanco-Reina; Aurelio Gomez Luque


Archive | 2015

Risk and protective factors for release in outpatients with schizophrenia

Inmaculada Bellido-Estevez; C Lopez; M Victoria Bellido; Encarnación Blanco-Reina; A. Gómez-Luque


Archive | 2015

Underuse of indicated medications in elderly

Encarnación Blanco-Reina; Gabriel Ariza-Zafra; Ricardo Ocaña-Riola; I. Medina-Cáliz; Elisa Isabel Marquez; Inmaculada Bellido-Estevez


Archive | 2015

Filmed clinical cases improved communication skills of student of Pharmacology in Podiatry degree

Inmaculada Bellido-Estevez; Encarnación Blanco-Reina; Elisa Isabel Marquez; Juan Antonio García-Arnés; Juan De Pablo; Aurelio Gomez-Luque


Archive | 2014

Avatars and Cartoons reduce anxiety in pediatric inpatients

Inmaculada Bellido-Estevez; M Victoria Bellido; A. Gómez-Luque


Archive | 2014

Compassionate use of medicinal products: a multicenter study

Encarnación Blanco-Reina; Azucena Muñoz-García; Manuel Jesús Cárdenas Aranzana; Ramón Morillo Verdugo; José Luís Moreno; Begoña Muros; Inmaculada Alférez; Meritxell Salazar; Inmaculada Bellido-Estevez; Monica Saldaña Valderas


Archive | 2013

The antidepressant effect of hypericum perforatum extract Ze 117 is associated with reduced possibilities of drug interactions than hypericum perforatum extract LI 160.

Inmaculada Bellido-Estevez; Maria Rosario Cabello-Porras; Encarnación Blanco-Reina; Elisa Isabel Marquez; M Victoria Bellido; A. Gómez-Luque

Collaboration


Dive into the Inmaculada Bellido-Estevez's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ricardo Ocaña-Riola

Andalusian School of Public Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge